Tokushima, Japan

Takefumi Shimizu

This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takefumi Shimizu. Retrieved from https://idiyas.com/inventor/takefumi-shimizu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takefumi Shimizu: Innovator in Pharmaceutical Chemistry

Introduction

Takefumi Shimizu is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work at Otsuka Pharmaceutical Company, Limited. His research focuses on developing new compounds that can improve health outcomes.

Latest Patents

Takefumi Shimizu holds a patent for a quinoline derivative and an antiulcer agent containing said quinoline. This invention represents a step forward in the treatment of ulcers, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Shimizu has demonstrated a strong dedication to research and development. His work at Otsuka Pharmaceutical Company, Limited has positioned him as a key player in the pharmaceutical industry. He has been instrumental in driving projects that aim to enhance therapeutic options for patients.

Collaborations

Shimizu has collaborated with esteemed colleagues, including Minoru Uchida and Seiji Morita. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Takefumi Shimizu's contributions to pharmaceutical chemistry and his innovative spirit exemplify the impact of dedicated inventors in the medical field. His work continues to inspire advancements that benefit society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…